Fluorescence-coded DNA Nanostructure Probe System to Enable Discrimination of Tumor Heterogeneity via a Screening of Dual Intracellular microRNA Signatures in situ-Reference-Cited by-同舟云学术

Fluorescence-coded DNA Nanostructure Probe System to Enable Discrimination of Tumor Heterogeneity via a Screening of Dual Intracellular microRNA Signatures in situ

Published:2017-10-18 Issue:1 Volume:7 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Shin Seung Won,Lee Byoung Sang^ORCID,Yang Kisuk,Amornkitbamrung Lunjakorn,Jang Min Su,Ku Bo Mi,Cho Seung-Woo,Lee Jung Heon,Bae Hojae,Oh Byung-Keun,Ahn Myung-Ju,Lim Yong Taik,Um Soong Ho^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/s41598-017-13456-3.pdf

Reference59 articles.

1. Hartwell, L. H., Hopfield, J. J., Leibler, S. & Murray, A. W. From molecular to modular cell biology. Nature 402, C47–C52 (1999).

2. Kitano, H. Systems biology: a brief overview. Science 295, 1662–1664 (2002).

3. Kelloff, G. J. & Sigman, C. C. Cancer biomarkers: selecting the right drug for the right patient. Nat. Rev. Drug. discovery 11, 201–214 (2012).

4. Freidlin, B. & Korn, E. L. Biomarker enrichment strategies: matching trial design to biomarker credentials. Nat. Rev. Clin. Oncol. 11, 81–90 (2014).

5. Borrebaeck, C. A. Precision diagnostics: moving towards protein biomarker signatures of clinical utility in cancer. Nat. Rev. Cancer 17, 199–204 (2017).